BRIEF published on 09/10/2024 at 14:30, 2 years ago FBR Ltd Completes First Home in US Demonstration Program FBR Limited Hadrian X® US Demonstration Program Wall As A Service® CRH Ventures
BRIEF published on 09/10/2024 at 14:30, 2 years ago FBR Ltd achève la première maison de son programme de démonstration aux États-Unis CRH Ventures FBR Limitée Hadrien X® Programme De Démonstration Américain Mur En Tant Que Service®
PRESS RELEASE published on 09/10/2024 at 14:25, 2 years ago First Home in Demonstration Program Complete FBR Limited completes first home in US with CRH Ventures, marking a milestone in Hadrian X® use outside Australia, contracts signed for seven homes with Florida builders FBR Limited US Demonstration Program CRH Ventures Hadrian X Florida Builders
Published on 09/11/2026 at 04:00, 3 hours 30 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 9 hours 5 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 16 hours 10 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 16 hours 30 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 00:05, 7 hours 24 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 00:01, 7 hours 29 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 8 hours 50 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 9 hours 19 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/10/2026 at 22:07, 9 hours 22 minutes ago EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board
Published on 09/11/2026 at 07:00, 30 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 30 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
